Authors: Prevost, GP Pradines, A Brezak, MC Lonchampt, MO Viossat, I Ader, I Toulas, C Kasprzyk, P Gordon, T Favre, G Morgan, B

Citation: Gp. Prevost et al., Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of human farnesyltransferase, BIM-46228, INT J CANC, 91(5), 2001, pp. 718-722

Authors: Cohen-Jonathan, E Toulas, C Ader, I Monteil, S Allal, C Bonnet, J Hamilton, AD Sebti, SM Daly-Schveitzer, N Favre, G

Citation: E. Cohen-jonathan et al., The farnesyltransferase inhibitor FTI-277 suppresses the 24-kDa FGF2-induced radioresistance in HeLa cells expressing wild-type RAS, RADIAT RES, 152(4), 1999, pp. 404-411

Authors: Broet, P Spyratos, F Romain, S Quillien, V Daver, A Ricolleau, G Rallet, A Toulas, C Asselain, B

Citation: P. Broet et al., Prognostic value of uPA and p53 accumulation measured by quantitative biochemical assays in 1245 primary breast cancer patients: a multicentre study, BR J CANC, 80(3-4), 1999, pp. 536-545